查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878871

動物疫苗市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、動物類型、給藥途徑、配銷通路、地區和競爭格局分類，2020-2030年預測

Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Route Of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球動物疫苗市場規模為76.8億美元，預計2030年將以8.69%的複合年成長率成長至126.6億美元。全球動物疫苗市場涵蓋旨在刺激包括家畜和伴侶動物在內的各種動物對傳染病產生免疫力的生物製劑。這些疫苗對於疾病預防、降低死亡率和透過控制人畜共患病傳播來保護公眾健康至關重要。

市場概覽
預測期 2026-2030
2024年市場規模 76.8億美元
2030年市場規模 126.6億美元
2025-2030年複合年成長率 8.69%
成長最快的細分市場 家畜
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球動物疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（減毒活疫苗、去活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
    • 依動物類型（家畜、伴侶動物、其他）
    • 依給藥途徑（皮下、肌肉內、鼻內）
    • 依配銷通路（獸醫院、獸醫診所、藥房及其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美動物疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲動物疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區動物疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲動物疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美動物疫苗市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球動物疫苗市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd.
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ouro Fino Saude Animal

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 5071

The Global Animal Vaccine Market , valued at USD 7.68 Billion in 2024, is projected to experience a CAGR of 8.69% to reach USD 12.66 Billion by 2030. The global animal vaccine market comprises biological preparations designed to stimulate immunity against infectious diseases across various animal species, including livestock and companion animals. These vaccines are crucial for disease prevention, mortality reduction, and public health protection by controlling zoonotic transmission.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.68 Billion
Market Size 2030USD 12.66 Billion
CAGR 2025-20308.69%
Fastest Growing SegmentLivestock
Largest MarketNorth America

Key Market Drivers

The global animal vaccine market is primarily influenced by the rising incidence of zoonotic diseases and the increasing global demand for animal-derived food products. Zoonotic diseases, transmissible between animals and humans, necessitate extensive animal vaccination to mitigate public health risks. For example, according to Forbes, in December 2024, a major mpox epidemic in the Democratic Republic of the Congo and neighboring countries recorded over 16,000 confirmed cases, prompting a public health emergency declaration from the World Health Organization. This underscores the critical role of veterinary vaccines in preventing disease transmission at the human-animal interface.

Key Market Challenges

The substantial cost associated with vaccine research, development, and stringent regulatory approval processes represents a significant impediment to the expansion of the Global Animal Vaccine Market. These extensive financial requirements elevate production expenses, directly impacting vaccine accessibility and affordability, particularly within developing economies where resources are often constrained. The prolonged timelines and complex regulatory pathways demand considerable capital investment, which restricts the number of new vaccines brought to market and limits the capacity for existing ones to be widely distributed at competitive prices.

Key Market Trends

The Global Animal Vaccine Market is significantly influenced by the rapid advancements in next-generation vaccine technologies. This trend encompasses the development of more sophisticated solutions such as recombinant, subunit, and mRNA-based vaccines, moving beyond traditional attenuated or inactivated forms. These innovative vaccines offer enhanced efficacy, improved safety profiles, and often enable faster development cycles and more targeted protection against specific pathogens. According to the World Health Organization's (WHO) 2024 Global Vaccine Market Report, in 2023, 88 vaccine products were sold across 207 countries by 116 manufacturers, underscoring the broad market where technological advancements are being applied.

Key Market Players

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd.
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ouro Fino Saude Animal

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Vaccine Market , By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Animal Vaccine Market , By Animal Type:

  • Livestock
  • Companion
  • Others

Animal Vaccine Market , By Route Of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal

Animal Vaccine Market , By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

Animal Vaccine Market , By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Vaccine Market .

Available Customizations:

Global Animal Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 5.2.2. By Animal Type (Livestock, Companion, Others)
    • 5.2.3. By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Animal Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal Type
    • 6.2.3. By Route Of Administration
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Route Of Administration
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Animal Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Route Of Administration
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Animal Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Route Of Administration
        • 6.3.3.2.4. By Distribution Channel

7. Europe Animal Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal Type
    • 7.2.3. By Route Of Administration
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Route Of Administration
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. France Animal Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Route Of Administration
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Animal Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Route Of Administration
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Animal Vaccine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Route Of Administration
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Animal Vaccine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Route Of Administration
        • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Animal Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal Type
    • 8.2.3. By Route Of Administration
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Route Of Administration
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Animal Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Route Of Administration
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Animal Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Route Of Administration
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Animal Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Route Of Administration
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Animal Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Route Of Administration
        • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Animal Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal Type
    • 9.2.3. By Route Of Administration
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Route Of Administration
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. UAE Animal Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Route Of Administration
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. South Africa Animal Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Route Of Administration
        • 9.3.3.2.4. By Distribution Channel

10. South America Animal Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal Type
    • 10.2.3. By Route Of Administration
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Route Of Administration
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Colombia Animal Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Route Of Administration
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Argentina Animal Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Route Of Administration
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Vaccine Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck & Co., Inc.
  • 15.3. Boehringer Ingelheim International GmbH
  • 15.4. Biogenesis Bago SA
  • 15.5. Indian Immunologicals Ltd.
  • 15.6. Elanco Animal Health Incorporated
  • 15.7. Phibro Animal Health Corporation
  • 15.8. Neogen Corporation
  • 15.9. Intas Pharmaceuticals Ltd.
  • 15.10. Ouro Fino Saude Animal

16. Strategic Recommendations

17. About Us & Disclaimer